Babita Kirodian
About Babita Kirodian
Babita Kirodian is the Head of Country Pharmacovigilance at Bristol-Myers Squibb and a Global Safety Manager at Amgen Technology, with over 20 years of experience in the pharmaceutical and biotechnology industries.
Title
Babita Kirodian holds the title of Head of Country Pharmacovigilance at Bristol-Myers Squibb in New York, New York, United States.
Current Positions
Babita Kirodian is currently working at Amgen Technology as a Global Safety Manager, located in Bombay, Maharashtra, India. She also serves as the Head of Country Pharmacovigilance at Bristol-Myers Squibb based in New York, New York, United States.
Previous Employment
Babita Kirodian worked at Abbott from 2003 to 2008 as a Manager in Regulatory Affairs and an Affiliate Safety Representative. During her five-year tenure at Abbott, she gained substantial experience in regulatory affairs and safety management.
Education and Expertise
Babita Kirodian studied at Seth G.S. Medical College & KEM Hospital, where she earned her Doctorates, Doctor of Philosophy, from 1995 to 2002. She has over 20 years of experience in the pharmaceutical and biotechnology industries, with a strong background in regulatory compliance and safety regulations.
Pharmaceutical Industry Experience
Starting her career in regulatory affairs and safety management in 2003, Babita Kirodian has extensive experience in pharmacovigilance. She has worked in various international locations, including India and the United States, ensuring the safety and efficacy of pharmaceutical products.